Agios Pharmaceuticals | Betriebsergebnis



Operating Profit Veränderung Datum
AbbVie USD 3.73B 5.22B 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Amgen USD 1.29B 1.02B 2025-03
Arrowhead Research USD 381.2M 542.61M 2025-03
Astellas Pharma JPY 92.54B 29.02B 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Bayer EUR 2.32B 1.21B 2025-03
Biogen USD 851.8M 540.6M 2025-06
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Daiichi Sankyo JPY 96.71B 13.1B 2025-06
Eli Lilly USD 5.41B 259.6M 2025-03
Exelixis USD 215.68M 28.82M 2025-07
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.02B 193M 2025-06
Incyte USD 310.82M 105.66M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
Merck USD 6.36B 494M 2025-06
Moderna USD -1050000000 196M 2025-03
Novartis USD 4.86B 201M 2025-06
Novartis USD 3.4B 193M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12


Agios Pharmaceuticals Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.